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VANCOMYCIN DAN VANCOMYCIN/BETA -SIKLODEKSTRIN KOMPLEKS: 
PENCIRIAN FISIKOKIMIKAL DAN PENILAIAN SITOTOKSISITI 
TERHADAP SEL GLIAL MANUSIA 
 
 
ABSTRAK 
 
Dalam kajian ini, kompleks vancomycin, sejenis antibiotik glikopeptida spektrum luas 
bersama β-CD pada nisbah molar yang sama dihasilkan dan dinilai bagi mengkaji tahap 
kesesuaiannya dalam pembentukan jenis antibiotik baru yang bersifat prolonge-released. 
Kompleks β-CD/vancomycin disediakan melalui dua kaedah iaitu penyejuk-keringan 
dan pengulian. Pembentukan kompleks disahkan melalui Analisis Difraktometri X-ray 
(XRD), Analisis Termal (TGA), Imbasan Mikroskop Elektron (SEM) dan juga 
Spektroskopi Transformasi Inframerah (FT-IR). Kesemua data yang direkodkan 
menyokong antara satu dengan yang lain membuktikan pembentukan kompleks. 
Difraktogram XRD yang diperoleh mempamerkan penurunan ketara sifat kristaliniti 
bagi setiap kompleks menunjukan kehadiran vancomycin di dalam molekul kompleks. 
Perubahan ketara morfologi permukaan dapat dilihat antara kompleks dengan β-CD dan 
vancomycin pada imej-imej SEM yang diambil. Perbezaan profil termal yang diperoleh 
antara kompleks dan molekul pemula pula menandakan kewujudan interaksi antara β-
CD dan vancomycin. Selain itu, variasi pada spektra IR termasuk pengembangan, 
anjakan dan pengurangan keamatan relatif jalur penyerapan dapat dilihat pada spektra 
kedua-dua kompleks. Kehilangan jalur penyerapan molekul tetamu dapat dijadikan 
sebagai pengesahan pembetukan kompleks β-CD/vancomycin. Walaubagaimanapun, 
daripada data yang diperoleh, kompleks pengulian terbukti lebih efisien dalam 
xiv 
 
memanjangkan tempoh penghantaran vancomycin berbanding kompleks penyejuk-
kering. Kesan sitotoksik vancomycin dan kompleksnya turut dikaji ke atas sel glial 
manusia dengan menggunakan kaedah MTS. Kesan kebergantungan terhadap dos secara 
linear diikuti dengan kesan secara hermetic-like biphasic dapat dilihat selepas tempoh 
inkubasi selama 72 jam. Peningkatan proliferasi sel secara signifikan (p<0.001) dapat 
dikesan pada kepekatan yang rendah : < 18.75 μg/ml untuk sel yang didedahkan kepada 
β-CD dan juga kompleksnya sementara < 9.38 μg/ml untuk sel yang terdedah kepada 
vancomycin. Namun, penurunan proliferasi sel secara signifikan (p<0.001) pula 
direkodkan pada kepekatan yang tinggi > 150 μg/ml pada semua kumpulan sel yang 
dikaji. 50 % perencatan (IC50) in vitro dicapai pada kepekatan 115.95 μg/ml (untuk β-
CD), 116.48 μg/ml (untuk vancomycin) and 115.44 μg/ml (untuk kompleks β-
CD/vancomycin). Secara keseluruhannya, berdasarkan keupayaan β-CD untuk secara 
signifikan (p<0.001) memanjangkan tempoh penghantaran vancomycin selain nilai IC50 
yang tinggi secara relatif yang diperoleh di dalam kajian ini menjadikan hasil kompleks 
yang dikaji sebagai produk yang berpotensi untuk digunakan sebagai site-specific 
administration bagi rawatan jangkitan terpencil pada sistem saraf pusat (CNS) oleh 
bakteria gram-positif pada masa hadapan.  
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VANCOMYCIN AND ITS BETA-CYCLODEXTRIN COMPLEX: 
PHYSICOCHEMICAL CHARACTERIZATION AND ITS CYTOTOXICITY 
EVALUATION ON HUMAN GLIAL CELL LINE 
 
 
ABSTRACT 
 
In this present study, the equimolar complexes of vancomycin, a broad-spectrum 
glycopeptide antibiotic with β-CD were prepared to evaluate their suitability for the 
development of a prolonged-release form of the antibiotic. β-CD/vancomycin complexes 
were prepared accordingly via freeze-drying and kneading techniques. The formation of 
the complexes was confirmed through X-ray Diffractometry (XRD), Thermogravimetric 
Analysis (TGA), Scanning Electron Microscopy (SEM) and Fourier Transfrom Infrared 
Spectroscopy (FT-IR). The results obtained were all in good agreement suggesting the 
successive formation of the aforementioned binary systems. The XRD diffractograms of 
the complexes showed marked reduction in crystalinity which indicates the presence of 
vancomycin in the complexes. In the SEM microimages captured, significant difference 
in surface morphology was observed between the complexes and the starting materials. 
Distinct thermal profiles between the complexes and the pure molecules recorded signify 
the existence of possible reciprocal interactions between the two molecules. Spectral 
variations included broadening, shifting and reduction in relative intensities of the 
absorption bands were also observed in the IR spectra of both complexes. Apart from 
that, the disappearance of guest signals in the complexes spectra can be considered as a 
confirmation for the formation of β-CD /vancomycin complexes. However, from the 
experiments it was found that the kneaded complex was more efficient in prolonging the 
xvi 
 
delivery of vancomycin compared to the freeze-dried complex. The possible cytotoxic 
effects of vancomycin and its complex with β-CD on human glial cell were assayed by 
means of MTS assay. A linear dose-dependency cytotoxicity followed by hermetic-like 
biphasic dose-dependence was observed after incubation period of 72 hours. Significant 
(p<0.001) increase of cell proliferation was observed at lower concentrations: < 18.75 
μg/ml for cells treated with β-CD and their complex while < 9.38 μg/ml for cells treated 
with vancomycin. In contrary, regardless of the treatments given, significant (p<0.001) 
reduce in cell survival was found at higher concentrations > 150 μg/ml. In particular, 50 
% inhibitory (IC50) in vitro were achieved at the concentrations of 115.95 μg/ml (for β-
CD), 116.48 μg/ml (for vancomycin) and 115.44 μg/ml (for β-CD/vancomycin 
complex). All in all, due to the ability of β-CD to significantly (p<0.001) control the 
delivery of vancomycin over a prolonged period of time provided with relatively high 
IC50 value calculated from this study renders this complex a promising product to be 
used in the future for site-specific administration of vancomycin for the treatment of 
localized gram-positive bacterial infections in CNS.  
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CHAPTER 1 
INTRODUCTION 
 
 
Medicinal chemistry is a branch of scientific disciplines which provides a common 
ground between chemistry, medical and pharmaceutical fields. It is an interdisciplinary 
field which involves designing, formulating, synthesizing as well as isolating of 
pharmaceutical drugs neither from plants nor synthetically produced for potential 
therapeutic use. Over the past few decades, technology advancement in the related areas 
has brought researches closer to meeting the goals of maximum efficacy with minimal 
toxicity and aggravation. 
 
For years, the development of a controlled and targeted drug delivery system has 
become of great interest to researches as the system will enable the delivery of the drugs 
at the desirable therapeutic level directly to the targeted areas for prolonged periods of 
time while avoiding high systemic doses. The used of polymeric materials including 
polymer micelles and polymeric microspheres likewise hydrogel-like materials has been 
reported to be effective in developing the system (Blanchemain et al., 2008; Figueiras et 
al., 2007; Silva-Jùnior et al., 2008; Sohajda et al., 2009; Veyries et al., 1999).  
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1.1       Cyclodextrins (CDs) 
 
Generally, degradation of starch via enzymatic process will result in the formation of 
dextrins; a long series of linear or branched chain of malto-oligomers. Dextrins are 
heterogenous, amorphous and hygroscopic substances.  They are produced in large 
quantities for numerous industry purposes. However, when the starch is degraded by the 
cyclodextrin-transglycosylase enzyme (CGT-enzyme), the primary product of the chain 
splitting undergoes an intramolecular reaction to form the α-1,4-linked cyclic dextrins or 
also known as cyclodextrins (CDs) in the absence of water molecule (Szetjli, 1998).  
 
In 1891, the first publication on CDs was reported by Villiers, a French author 
following his observation on some unidentified crystalline substances during the 
fermentation process of starch (Szetjli, 1998). According to Szetjli (2004), the long 
history of the revolutionary process of CDs can be divided into three major stages which 
started with the “discovery” period from 1891 to the middle of 1930s, followed with the 
“exploratory” period from 1936 until 1970 and ended up with the “utilization” period 
from 1970 onward.  
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1.1.1 Properties and classification of CDs 
 
CDs are characterized as crystalline, homogenous, non-hygroscopic substances. The 
structure of CD is often described as a truncated cone. The exterior surface is 
hydrophilic while the interior cavity is relatively hydrophobic (Wang et al., 2007a). 
They are alpha-cyclodextrin (α-CD, also known as Schardinger’s α-dextrin, 
cyclomaltohexaose, cyclohexaglucan, cyclohexaamylose, ACD, C6A), beta-cyclodextrin 
(β-CD, also known as Schardinger’s β-dextrin, cyclomaltoheptose, cycloheptaglucan, 
cycloheptaamylose, BCD, C7A) and gamma-cyclodextrin (γ-CD, also known as 
Schardinger’s β-dextrin, cyclomaltooctatose, cyclooctaglucan, cyclooctaamylose, GCD, 
C8A) which are formed by six, seven and eight glucopyranose units, respectively 
(Szetjli, 2004).  
 
Theoretically, larger CDs with ten or more ring members could be prepared. 
Nonetheless, due to their expected high solubility and weak complex forming ability, the 
challenge seems to be unrewarding. On the other hand, CDs with fewer than six 
glucopyranose units cannot be formed for steric reasons. All hydroxyl groups are located 
on the edges of the cavity where the secondary hydroxyl groups are placed on the edge 
with wider diameter while the primary hydroxyl groups accommodated the other edge 
with narrower diameter. The free rotation of the primary hydroxyl groups reduces the 
effective diameter of the cavity (Szetjli, 2004). Figure 1.1 exhibits the chemical structure 
of the three common types of native or parent CDs. 
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Figure 1.1 Chemical structure of native cyclodextrins; alpha-cyclodextrin (α-CD), 
beta-cyclodextrin (β-CD) and gamma-cyclodextrin γ-CD (Szetjli, 2004) 
 
 
The hydrogen bonds and also the glucosidic-oxygen bridges (Figure 1.2) linked 
the glucopyranose units together and help to keep the cavity in shape. 
 
 
 
 
 
 
 
 
Figure 1.2 The glucosidic oxygen bridge α-(1, 4) between two molecules of 
glucopyranose (Astray et al., 2009) 
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The nonbonding electron pairs of the glucosidic-oxygen bridges are directed 
towards the inner part of the cavity, producing a high electron density environment and 
lending some Lewis-base characters to it. The C-2-OH group of one glucopyranose unit 
can be linked with the C-3-OH group of the adjacent glucopyranose unit via hydrogen 
bond (Szetjli, 2004). Figure 1.3 shows the approximate geometry of α-CD, β-CD and γ-
CD. 
 
Figure 1.3 Approximate geometry of a) α-CD, b) β-CD and c) γ-CD (Astray et al., 
2009) 
 
A complete secondary belt is formed by these hydrogen bonds in the β-CD 
molecule contributing to a rigid structure of the β-CD. Thus, the formation of these 
intramolecular hydrogen bondings in β-CD explained its lowest solubility of all CDs. In 
contrast, because of one glucopyranose unit is in a distorted position in the α-CD 
molecule, a complete secondary belt cannot be formed. As a consequence, only four out 
of six possible hydrogen bonds can be established.  The γ-CD is a non-coplanar, more 
flexible structure and therefore it is the most soluble CD (Astray et al., 2009). Amongst 
a b c 
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the common types of CDs, β-CDs appeared as the most accessible, the lowest-priced and 
generally the most useful of all (Martin Del Valle, 2004). Apart from that, reports by 
other authors have shown the ability of β-CDs to improve the physicochemical 
properties of the entrapped guest molecule including to sustained-release of water-
soluble drugs (Hirayama and Uekama,1999; Keipert et al., 1996). Table 1.1 summarizes 
the characteristics of α-CD, β-CD and also γ-CD. 
 
Table 1.1 Characteristics of α-CD, β-CD and also γ-CD (Frömming and Szetjli, 1994) 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 α β γ 
Number of glucose units 6 7 8 
Molecular weight 972 1135 1297 
Solubility in water g/100 ml 14.5 1.85 23.2 
Cavity diameter, Å 4.7 - 5.3 6.0 - 6.5 7.5 - 8.3 
Height of torus, Å 7.9 + 0.1 7.9 + 0.1 7.9 + 0.1 
Approx. volume of cavity, Å
3
 174 262 427 
Approx. cavity volume in 1 mol 
CD (ml) in 1 g CD (ml) 
104 1257 
 
427 
 
Crystal forms (form water) 
Hexagonal 
plates 
Monoclinic 
parallelelograms 
 
Quadratic 
prisms 
 
Crystal water weight, % 10.2 13.2-14.5 8.13-17.7 
Diffusion constant at 40 
o
C 3.443 3.223 3.000 
pK (by potentiometry) at 25 
o
C 12.332 12.202 12.081 
Partial molar volumes in solution 
(ml mol
-1
) 
 
611.48 
 
703.8 
 
801.2 
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1.1.2 CD inclusion complexes and host-guest concepts 
 
The most unique characteristic of CDs is their capability to form inclusion complex with 
a broad range of molecules ranging from solid, liquid and gases. Inclusion in CDs exerts 
profound effects on the physicochemical properties of the entrapped guest molecules as 
they are temporarily caged within the host cavity. The potential guest molecules 
including straight or branched aliphatics, aldehydes, ketones, alcohols, organic acids, 
fatty acids, aromatics, gaseous and polar compounds such as halogens, oxyacids and 
amines (Schmid, 1989). This inclusion phenomena results in solubility enhancement of 
highly insoluble guests, stabilization of labile guests against degradative effects of 
oxidation, visible or UV light and heat, control of volatility and sublimation, physical 
isolation of incompatible compounds, chromatographic separations, taste modification 
by masking off the flavour, unpleasant odours and controlled release of drugs and 
flavours (Szetjli, 1998; Hollands et al., 1999; Bharwaj et al., 2000). 
 
 The term Einschlussverbindung (or inclusion compound) was introduced by 
Sclenk in 1950 as cited by Frömming and Szetjli (1994). There are some other names 
used in the literature, such as adduct, clathrate, molecular compound, cryptate and 
complex. Inclusion complexes are entities built up from two or more molecules, in 
which the guest molecules are entrapped (totally or partially) only by physical forces 
without covalent bonding (Astray et al., 2009).  The main driving force of the complex 
formation is the release of enthalpy-rich water molecules from the CD cavity.  
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Water molecules are displaced with the more hydrophobic guest molecules 
present in the solution to attain an apolar-apolar interaction and reduce of CD ring strain 
resulting in a more stable energy state (Szetjli, 1998). The interactions between host (H) 
and guest (G) normally are based on simultaneous non-covalent interactions between 
single binding sites, A (acceptor) and D (donor), etc. No covalent bonds are formed nor 
broken during the formation of the inclusion complex. Figure 1.4 illustrates an example 
of the CD structure and inclusion complex formation through host-guest interactions 
(Frömming and Szetjli, 1994). 
 
  
Figure 1.4 Cyclodextrin structure and host-guest complex formation (Frömming and 
Szetjli, 1994) 
 
 
 
 
 
 
Guest molecule Host molecule Host-guest complex 
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1.1.3 Toxicological aspects of beta-cyclodextrin (β-CD) 
 
The novel attempt to evaluate the toxic effects of β-CD was initiated by French and 
Thomas back in 1957. The experiments were carried out by feeding the rats with highly 
purified β-CD in which β-CD was partly included in the carbohydrate diet of the 
animals. The results were rather discouraging as it was reported in the monograph that 
the animals refused to eat the test diet except in very small quantities and were found 
dead in the following week. However, cause of death was not revealed in the 
postmortem reports (Frömming and Szetjli, 1994). Since then, further studies have been 
carried out and none of them came out with similar results as reported by French and 
Thomas.  
 
When administrated intravenously (i.v) to rats, the median lethal dose (LD50) of 
β-CD was 788 mg/kg. Sign of nephrotoxicity including severe nephrosis but no deaths 
was observed in rats given with 1, 2, 4 or daily injection of β-CD at 450 mg/kg. Daily 
subcutenous (s.c) injection of 200 mg β-CD (equivalent to 840 mg/kg) over a period of 
seven days of treatment resulted in a strong swelling of the kidneys as well necrosis in 
the subcutenous connective tissues. The LD50 via intraparetonial (i.p) route of β-CD 
were 373 and 356 mg/kg in male and female rats, respectively. As in mice, the values 
showed small deviation as the values calculated were 372 mg/kg for male and 331 
mg/kg in female. In addition, when administrated orally, the LD50 were as follows: 12.5 
g/kg in mice, 18.8 g/kg in rats and > 5g/kg in dogs (Bellringer et al., 1994).    
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Moreover, the cytotoxicity studies of β-CD have been reported before and the 
results were found to be varied depending on the types of cell studied (Hipler et al., 
2007; Piel et al., 2004; Tilloy et al., 2006) 
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1.2 Vancomycin  
1.2.1 Structure 
 
Vancomycin was first isolated from Amycolatopsis orientalis which was found in 
Borneo Island in 1956. However due to its impurities, only 30 years later vancomycin 
starting to gain increasingly popularity in medical application and serves as antibiotic of 
last resort in the treatment of gram-positive bacterial infections (Veyries et al., 1999; 
Loll and Axelsen, 2000). According to commonly accepted classification which is based 
on type of residues at position I and III, glycopeptide antiobiotics can be classified into 
five different classes in which class I-IV are proven to have antimicrobial activities (Loll 
and Axelsen, 2000).   
 
Generally, all glycopeptide antibiotics share a common heptapeptide core of 
seven amino acid residues with three characteristic rings system in the aromatic side 
chains of residues 2 and 4, 4 and 6, and 5 and 7 which are covalently joined in addition 
to diverse composition of sugar moieties and attachment sites of chlorine. Vancomycin 
together with balhimycin, eremomycin, chloroeremomycin and LY 33328 are in class I 
glycopeptide antibiotics. In comparison to the other subclasses of glycopeptide 
antibiotics, class I glycopeptides bearing aliphatic amino acids at position I and III. Class 
II glycopeptides (e.g. actinoidin) possess aromatic residues while class III (e.g. 
ristocetin) and IV (e.g. teicoplanin) share similar general architecture, but however, class 
IV in addition have a fatty acid attached to the sugar residue. On the other hand, class V 
glycopeptides (e.g. complestatin) only have two instead of three ring systems (Loll and 
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Axelsen, 2000). Figure 1.5 shows the chemical structure of class I glycopeptide 
antibiotics.  
 
 
Figure 1.5   Chemical structure of class I glycopeptide antibiotics (Loll and Axelsen, 
2000) 
 
Vancomycin 
X=Y=Cl 
Balhimycin 
X=Y=Cl 
Eremomycin 
X=Y=Cl 
(A82846A) 
Chloroeremomycin 
X=Y=Cl 
(A82846B) 
LY 333328 
X=Y=Cl 
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1.2.2 Mechanism of action  
 
Vancomycin has a relatively high molecular mass (~1400 Da) and this makes 
vancomycin and its analogues unable to penetrate the inner membrane of bacterial cell 
wall. In order to deal with such deficiency, vancomycin will bind to the bacterial cell 
wall and interfere during the late phases of peptidoglycon biosynthesis. The inhibition of 
peptidoglycon biosynthesis is due to binding of vancomycin to the –D-Ala-D-Ala 
terminus of peptidoglycon in bacterial cell wall. By doing such, vancomycin blocks the 
transglycosilation and transpeptidation steps and cause the bacterial cells become 
susceptible to lysis (Loll and Axelsen, 2000).  
 
Vancomycin is known for its ability to form dimer in aqueous solution (Backes 
et al., 1998). The first report on aggregation of vancomycin in an aqueous solution was 
first studied and documented by Neito and Perkins in 1971. It was shown that in the 
dimer, hydrogen bond interactions were formed between the back sides of the two 
antibiotic molecules (Figure 1.6). The resulting formation of homodimer increases the 
affinity towards cell wall fragment up to a factor of ten. In turn, cell wall fragments were 
reported to enhance dimerization by factors of two to 100 (Loll and Axelsen, 2000). 
Based on this information one can assume that the process of dimerization plays potent 
role in the physiological mode of action of a number of vancomycin-type antibiotics.  
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Figure 1.6 Schematic intermolecular relationships. (Top) The antiparallel orientation 
of Ac-D-Ala-D-Ala relative to the heptapeptide backbone of a glycopeptide antibiotic, 
and its intermolecular hydrogen bond configuration. (Bottom) The dimeric relationships 
seen in crystals of vancomycin/Ac-D-Ala complex. The back-to-back interface is 
stabilized by four hydrogen bonds as well as numerous hydrophobic contacts (Loll and 
Axelsen, 2000). 
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1.2.3 Toxicological aspects of vancomycin 
  
During 1960s, the leading role of vancomycin was replaced by the less toxic agents such 
as methicillin, semisynthetic penicillins and cephalosporins due to its impurities issues 
(Loll and Exelsen, 2000). After more than 20 years of studies done on the toxicological 
aspects of this drug, the results showed that the administration of this drug may cause 
few adverse affects in animal models including local irritation following parenteral 
administration, nephrotoxicity and a significant drop of blood pressure after rapid 
intravenous (i.v) administration in dogs (Wold and Turnipseed, 1981).  Similar 
observations were also reported in clinical use of vancomycin where local irritation at 
the site of injection, nephrotoxicity and histamine-like responses were reported 
occasionally. In addition, vancomycin administration showed no signs of ototoxicity 
unless given in combination with aminoglycosides in laboratory animals (Farber and 
Moellering, 1983).  
 
Wold and Turnipseed (1981) summarized their findings on the acute toxicity 
study of vancomycin in laboratory animals as follows: i.v median lethal dose (LD50) of 
vancomycin for rats, mice and dogs were 319, 489 and 292 mg/kg, respectively. Rats 
and mice were found death in clonic convulsion after immediate dosing which signifed 
direct effects of the drug on the central nervous system (CNS). Moreover, from the 
results of their experiments, they then hypothesized that renal failure may associate with 
the mortality in dogs following several days of vancomycin administration. In contrary, 
administrations of vancomycin via subcutaneous (s.c) and oral (even at high 
concentration of 5g/kg) resulted in no deaths in mice. However, for s.c route, extensive 
 16 
 
necrosis and sloughing of the subcutaneous tissue were observed. The intraparetional 
(i.p) LD50 of vancomycin for rats and mice were 2218 mg/kg and 1734 mg/kg. Similarly 
to β-CD, previous reports on the cytotoxic effects of vancomycin also revealed mixture 
of results as the cytotoxic effects were shown to be depending on the nature of the cells 
(King and Smith, 2004; Yoeruek et al., 2008). Nonetheless, to the best of our 
knowledge, none of them were ever performed on human glial cells.  
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1.3 Glial cells 
1.3.1 Types of glial cells in human CNS 
 
Glial was first named in 1856 by Rudolf Virchow (Somjen, 1988). Generally, in human 
central nervous system (CNS), glial cells or also known as neuroglials refer to the major 
constituent of human brain cells including astrocytes, oligodendrocytes and microglials. 
Figure 1.7 illustrates the types of cells found in human CNS. Relatively to neurons, glial 
cells present at the ratio of ~ 1.65:1 in human cortex (Sherwood et al., 2006; 
Verkhratsky and Toescu, 2006). Astrocytes or astroglials are the main class and 
probably the most studied of neuroglials followed by oligodendrocytes and microglial. 
Astrocytes can be further sub-classified in two different types which are protoplasmic 
and fibrous astrocytes mostly based on the cell morphology (Miller and Raff, 1984). The 
size of human protoplasmic astrocyte was reported at about 2.5-3 times larger than 
fibrous astrocyte (Oberheim et al., 2009).  
 
According to Goldman (2001), astrocytes are originated from two sources. 
During early development, astrocytes are believed to form from elongated precursors 
that have their cell body in or near the ventricular zone and a process that stretches 
radically to terminate at the surface of the neural tube or developing brain. Later in 
development, astrocytes are generated from a distinct set of germinal areas, the 
subventricular zone. As for oligodendrocytes, the origin of these cells is still uncertain, 
however in analogy with the cord, ventral structures are most likely to be the major 
source for the production of oligodendrocytes (Richardson et al., 2006).  In addition to 
 18 
 
that, study by Kaur et al. (2001) suggested that some of microglial may arise from the 
pial mesenchymal macrophages that appear to originate from the yolk sac precursors.  
 
 
 
 
 
 
Figure 1.7 Types of glial cells in human CNS (Ganong WF. Review of medical 
physiology 22
nd
 edition (http://www.accessmedicine.com) 
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1.3.2 Importance of glial cells in human CNS 
 
In mammalian brain, astrocytes divide the grey matter into relatively independent 
structural units. The protoplasmic astrocytes occupy their own territory and create the 
microanatomical domains within the limits of their processes (Bushong et al., 2004). 
Within the confines of these anatomical domains, the membrane of astrocytes covers 
synapses and neuronal membranes as well as sends the process to plaster the wall of the 
neighbouring blood vessel with the end foot (Figure 1.8). 
  
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 1.8 The general arrangement between astrocytes, capplilaries and neurons. 
Astrocytes (white), capillaries (brown), neurons (green) and synaptic junctions (blue) 
(Prienger, 2002). 
 20 
 
 Meanwhile, oligodendroytes which are the second major class of neuroglials are 
actively communicating with neurons. This reciprocal signaling profoundly contributes 
to overall brain plasticity (Fields, 2008). From the homeostatic aspect, astrocytes 
appeared as the core cellular element of the extracellular homestasis in the brain. The 
control over the concentrations of ions, neurotransmitters, neuromodulators, metabolites 
and other active substances is of a paramount importance for normal operation of neural 
networks (Simard and Nedergaard, 2004). Neuroglials are non-excitable and therefore 
are unable to use plasmalemmal ion conductances to rapidly convey the information. 
Nonetheless, neuroglials on the other hand are able to develop of propagating signals 
either through the gap junctions or via the release of gliotransmitters. Conceptually, glial 
cells can perform all physiological processes as neurons do although the neuroglials 
execute these physiological processes in a specific and distinct way (Condorelli et al., 
1999; Gallo and Ghiani, 2000; Fraser et al., 1995; Verkhratsky and Toescu, 2006).  
 
 Besides that, glial cells are believed to play the leading role in initiation, 
progression and outcome of neurological diseases. Indeed in higher mammals, 
neuroglials are fully responsible for brain homeostasis, brain metabolic support and 
brain defense, as well as in every type of lesion to the CNS. In a way, this shows that 
neuroglials are important to withstand and repair the damage (Matute, 2010; Rossi and 
Volterra, 2009). The pathological of neuroglials are diverse including various 
programmes of activation, which are essential for limiting the areas of damage, 
producing neuro-immune responses and for the post-insult remodeling and recovery of 
neural function (Hasnich and Kettenmann, 2007; Rolls et al., 2009). 
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1.4         Recent studies 
 
Study by Tilloy et al. (2006) was conducted in order to evaluate the potential use of 
methylated-β-cyclodextrins (M-β-CD), a type of β-CD derivative in enhancing the 
delivery of doxorubicin (DOX), an anti-tumoral agent across an in-vitro model of blood-
brain barrier (BBB). β-CD and two methylated derivatives were used at a concentration 
preserving the BBB intergrity (1, 1 and 2.5 mM for β-CD, Rame-β-CD and Crysme-β-
CD, respectively). The concentration of DOX was fixed at 1 μM. In the study, it was 
found that M-β-CD was able to improve the delivery of DOX across the brain capillary 
endothelial cells (BCEC). The results showed that M-β-CD was able to reduce the P-gp 
activity by extracting the cholesterol which led to an enhancement of delivery of P-gp 
substrates. Release of cholesterol from BCEC was found to be dependent on the nature 
as well as the concentration of CDs used. The cholesterol efflux was equal to 16 %,    21 
% and 31 % for 1mM β-CD, 1mM Rame- β-CD and 2.5 mM Crysme- β-CD. 
 
Cannavá et al. (2009) reported the formation of an amphiphilic 
cyclodextrin/genistein complex via emulsification-difussion method at 1:1 molar ratio in 
water medium. Genistein (Gen) is an isoflavone belonging to the class of phytoestrogens 
has been considered as a potential remedy for many kinds of diseases. Gen molecules 
were shown to form a partially included complex with cyclodextrin. The lack of 
inclusion was confirmed by monitoring the significant differences in the spectral 
features of the Fourier Transform Infrared Spectrascopy-Attenuated Total Reflactance 
(FTIR-ATR) spectrum of complex with respect to the physical mixture, revealed in the 
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O-H, C=O, C=C, C-O-C and C-O stretching region. The differences evidenced the 
functional groups involved in the activation of the host-guest interaction during 
complexation process.  
 
Juelin et al. (2009) reported the role played by CD in enhancing the uptake of 
ribavirin (RBV) into the brain. RBV is a broad-spectrum antiviral agent and a water-
soluble synthetic nucleoside. It is ineffective against major viral encephalitis because of 
its failure to cross the blood-brain barrier. RBV improved the survival of subacute 
sclerosing panencephalitis (SSPE) virus-infected hamsters when only administrated 
intracranially and did not improve their survival when given intraperitoneally suggesting 
its failure to cross the BBB. In this study, RBV specific extraction from brain tissue was 
developed based on a solid phase extraction and quantified by high performance liquid 
chromatography (HPLC) at different interval points after intraperitoneal injection of 
single or multiple doses of free RBV or the complex RBV/alpha-cyclodextrin.  The 
amount of RBV was significantly higher (p<0.001) for the tested doses (40 or 100 
mg/kg) when the drug was injected as a complex with alpha-cyclodextrin in healthy of 
measles virus-infected mice. The results showed that RBV reached its effective 
concentration when injection in a complex formulation and proved that cyclodextrins are 
of a great interest for the treatment of human infectious diseases of central nervous 
system.  
 
Figueiras et al. (2007) performed a study to evaluate the formation of solid-state 
inclusion complexes of omeprazole (OME) with the native and the chemically modified 
β-CD and their dissolution profiles. The complexes were prepared via kneading, freeze-
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drying and spray-drying techniques in a 1:1 molar ratio. The formation and 
physicochemical characterization of the complexes were investigated by Differential 
Scanning Calorimetry (DSC), Fourier Transform-Infrared (FTIR), X-ray Diffractometry 
(XRD) and Scanning Electron Microscopy (SEM). Significant differences were 
observed between the dissolved drug amounts in pure, physically mixed and complexed 
forms (p < 0.001) as well as in the dissolution rate in artificial saliva media. The results 
proved that the complexation effectively enhanced solubility of OME, which 
consequently can increase its bioavailability and might improve its pharmaceutical 
potential.  
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1.5 Research objectives  
1.5.1 General objective  
 
In this study, the equimolar complexes of vancomycin, a broad-spectrum glycopeptides 
antibiotic with beta-cyclodextrin (β-CD) were prepared to evaluate their suitability for 
the development of a prolonged-release form of the antibiotic. Three specific objectives 
were studied accordingly.  
 
1.5.2 Specific objectives  
 
(i) To prepare and to characterize β-CD/vancomycin complexes formed by 
freeze-drying and kneading techniques.  
 
(ii) To study the dissolution patterns of vancomycin upon complexation with β-
CD produced via freeze-drying and kneading processes by using High 
Performance Liquid Chromatography (HPLC).  
 
(iii) To evaluate the cytotoxicity effects of vancomycin and its complex with β-
CD in human glial cell line. 
 
 
 
 
 
